Calls
1
u/EMRHNSMSKK
Reddit r/biotech_stocks
Win Rate
100.0%
return
+6.6%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Sep 13
$81.05
+6.6%
The author views TransMedics' current price as a potentially attractive entry point, citing the longer-term growth opportunity in its OCS technology and transplant logistics network. The implied mechanism is that scaling OCS adoption and the logistics network drives revenue growth over a multi-year horizon. The author explicitly flags slowing growth, margin pressure and heavy expansion spending as the main risks, and does not treat it as risk-free.
MedTech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/EMRHNSMSKK has 1 trade ideas tracked on Buzzberg across 1 tickers since September 2026. Most covered: TMDX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
